FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump to kick off Great American State Fair as 250th anniversary celebrations take over National Mall

Blue state shield laws allowed 330K abortion pills to be sent to abortion ban states, pro-life group finds

Antifa leaders panic after DOJ pursues conspiracy charges against Minnesota operatives

Far-left surge: Mamdani-backed candidates oust Dem establishment incumbents

Paroled felon charged in deadly fire at New York homeless hotel that killed 6

DOJ charges 10 Southern California defendants in largest federal healthcare fraud crackdown in US history

Top Dem beats progressive who likened himself to Bernie Sanders in closely watched race

‘Party of Zohran’: Mamdani emerges as Democratic kingmaker after socialist allies sweep NYC primaries

Biden appointee crushes comeback bid by billionaire wine mogul David Trone

Mamdani-backed socialist with history of anti-American rhetoric wins vicious Dem primary race

GOP voters pick Trump-backed nominee in battle to flip crucial House seat

Meet the Republican challengers vying to unseat New York’s congressional Democrats

Investigators revisit Florida serial killer case as search resumes for possible additional victims

Iranian World Cup Fans Defy Regime and FIFA with Banned Displays of Resistance

Biden-appointed judge ripped after blocking ICE arrests at immigration courts

See also Alan Greenspan dies at age 100

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”